U.S. to bolster public health workforce to fight COVID-19, future pandemics
Reuters
Published May 13, 2021 10:39AM ET
WASHINGTON (Reuters) - The Biden administration is releasing $7.4 billion to bolster the nation's healthcare workforce amid the ongoing COVID-19 pandemic and to prepare for future epidemics and health challenges, the White House said in a statement on Thursday.
The funds, allocated as part of the $1.9 trillion aid package pushed by President Joe Biden and passed by Congress in March, will be used to recruit and hire a range of healthcare workers to help with vaccinations, testing and contact tracing, it said.
Of the $7.4 billion, $4.4 billion will go to states and local public health departments to address disease outbreaks and hire school nurses. It will also be used to expand the U.S. Centers for Disease Control and Prevention's ability to track outbreaks and to create a service corps dedicated to public health. The remaining $3 billion will boost local public health workforces ahead of future challenges, with an emphasis on recruiting diverse candidates, the White House said.
The United States is making progress in its efforts to emerge from the coronavirus pandemic, which shut down much of the country last year and roiled the economy, with more than 582,000 deaths to date.
After a winter spike in COVID-19 infections, new cases have fallen for four straight weeks and deaths have also dropped as more than one-third of the country has been vaccinated. Warmer weather has also helped to curtain the spread of the virus.
Nearly 154 million people in the United States had received at least one dose of a COVID-19 vaccine as of Wednesday, U.S. officials said. The pace of vaccinations, however, has slowed and U.S. health officials have said variants such as the one emerging from India could still pose a threat.
Public health experts for years have decried a lack of funding for the CDC and other areas and have warned about the potential devastating impact from epidemics of SARS, Ebola, swine flu and other diseases.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.